Other
KKR is buying Envision Healthcare in a nearly $10B deal
KKR is buying physician services provider and surgery center operator Envision Healthcare Corp. in an approximately $9.9 billion deal.
Jun 11, 2018
0
1
News tagged with share price
Surgery
Helping patients shop around for health care could control costs better than current system
Most consumers haven't shopped around for standard medical procedures such as a knee replacement, but reference pricing could open that possibility for many services and lower health care costs at the same time.
Jul 15, 2019
0
2
Medications
Insulin gives Denmark's Novo Nordisk a Q1 boost
(AP)—Danish pharmaceutical company Novo Nordisk A/S says first-quarter net profit rose 28 percent on strong sales of its diabetic drugs.
May 1, 2013
0
0
Medications
GSK launches hostile $2.6 bn bid for Human Genome Sciences
British drugmaker GlaxoSmithKline on Wednesday said it had gone hostile over its $2.6 billion (2.0 billion-euro) takeover bid for US research partner Human Genome Sciences Inc.
May 9, 2012
0
0
Medical economics
Astra eyes record merger with drug rival Gilead: report
British pharmaceuticals group AstraZeneca has approached US rival Gilead Sciences over a possible record merger, Bloomberg reported, as the pair spearhead treatments for COVID-19.
Jun 8, 2020
0
1
Health
Understanding the strong promotion of unhealthy food
Unhealthy food dominated the weekly grocery store flyers. As much as two thirds of the space was taken up by less healthy foods according to a study from the University of Gothenburg. The advertising does not seem to support ...
May 31, 2023
0
10
Diseases, Conditions, Syndromes
Program to up access to combo malaria therapy successful
(HealthDay)—Implementation of a series of national-scale pilot programs designed to increase the access and use of quality-assured artemisinin-based combination therapies (QAACTs) for malaria by the Affordable Medicines ...
Nov 1, 2012
0
0
Medical economics
Pfizer to buy Array BioPharma in deal worth $11.4 billion
Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring.
Jun 17, 2019
0
0
Medications
Glaxo says China drugs sales slump on bribery probe (Update)
British drugmaker GlaxoSmithKline revealed on Wednesday that pharmaceuticals and vaccines sales in China tumbled 61 percent in the third quarter, as it was rocked by a state bribery probe.
Oct 23, 2013
0
0
